Department of Surgery, College of Medicine, Chung-Ang University, Seoul, Korea.
Surg Endosc. 2011 Oct;25(10):3183-90. doi: 10.1007/s00464-011-1684-3. Epub 2011 Apr 13.
The preemptive intravenous and intraperitoneal application of local anesthetics is known to improve the postoperative outcome in abdominal surgery. The aim of this study was to compare the analgesic effect of intravenous lidocaine injection to that of intraperitoneal lidocaine instillation in patients who were undergoing laparoscopic appendectomy (LA).
Sixty-eight patients who were undergoing LA for unperforated appendicitis were randomly divided into three groups. Group IP (the intraperitoneal instillation group) received intraperitoneal instillation of lidocaine and intravenous normal saline injection. Group IV (the intravenous injection group) received intravenous lidocaine injection and intraperitoneal instillation of normal saline. In group C (the placebo control group), normal saline was given both intravenously and intraperitoneally. The visual analog scale (VAS) of pain scores was measured after surgery. The needs for additional intravenous fentanyl were evaluated and the integrated fentanyl consumption (PCA delivered + additional fentanyl) was assessed. The incidence of shoulder tip pain and postoperative nausea and vomiting (PONV) were noted.
Reduction of the VAS score and of fentanyl consumption was noted in the IV and IP groups and compared to that of group C (P < 0.05). The shoulder tip pain and PONV were reduced in groups IP and IV compared to that in group C (P < 0.05). However, no significant differences were found between the IP and IV groups for all the studied variables. There was no adverse effect from intravenous lidocaine throughout the study.
Intravenous lidocaine injection is as effective as intraperitoneal instillation for reducing pain and fentanyl consumption. The major benefit of intravenous injection is that this is an easily and universally applicable procedure compared to that of intraperitoneal instillation. Lidocaine intravenous administration is a better alternative for reducing the pain of patients who are undergoing laparoscopic surgery.
预先静脉和腹腔内应用局部麻醉剂已被证明可以改善腹部手术的术后结果。本研究的目的是比较静脉注射利多卡因和腹腔内利多卡因灌注在腹腔镜阑尾切除术(LA)患者中的镇痛效果。
68 例因未穿孔阑尾炎而行 LA 的患者被随机分为三组。IP 组(腹腔内灌注组)接受腹腔内利多卡因灌注和静脉注射生理盐水。IV 组(静脉注射组)接受静脉注射利多卡因和腹腔内生理盐水灌注。在 C 组(安慰剂对照组)中,静脉内和腹腔内均给予生理盐水。术后测量视觉模拟评分(VAS)疼痛评分。评估需要额外静脉注射芬太尼,并评估芬太尼的总消耗量(PCA 输送+额外芬太尼)。记录肩痛和术后恶心呕吐(PONV)的发生率。
IV 组和 IP 组的 VAS 评分和芬太尼消耗量均低于 C 组(P<0.05)。与 C 组相比,IP 组和 IV 组的肩痛和 PONV 均减少(P<0.05)。然而,所有研究变量在 IP 组和 IV 组之间均无显著差异。整个研究过程中,静脉注射利多卡因无不良反应。
静脉注射利多卡因与腹腔内灌注一样有效,可减轻疼痛和芬太尼的消耗。与腹腔内灌注相比,静脉注射的主要优点是这是一种简单且普遍适用的方法。静脉内给予利多卡因是减轻接受腹腔镜手术患者疼痛的更好选择。